Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-19T04:05:49.904Z Has data issue: false hasContentIssue false

Pursuing Sleep Architecture Remodeling: Effects of Psychopharmaceuticals on Sleep Structure

Published online by Cambridge University Press:  27 August 2024

J. Camilo*
Affiliation:
Psychiatry, CHTMAD, Vila Real, Portugal

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Sleep plays a pivotal role in overall physical and mental health, exerting a profound influence on general well-being and quality of life. The influence of psychopharmaceuticals on sleep structure is a critical research area, given their widespread use in the treatment of psychiatric disorders, yet their precise effects on sleep remain inadequately understood.

Objectives

This study aims to investigate how psychopharmaceuticals affect sleep architecture by identifying commonalities and disparities among different classes of psychotropic medications.

Methods

Systematic review of the literature encompassing studies assessing the effects of psychopharmaceuticals on sleep structure. Electronic databases such as PubMed were employed to identify pertinent studies published within the last decade.

Results

Diverse classes of psychopharmaceuticals have varying effects on sleep architecture. Additionally, prolonged use of specific psychopharmaceuticals was correlated with sleep disturbances, such as insomnia. These findings hold significant implications for clinical practice, emphasizing the necessity of an individualized approach in treating patients with psychiatric disorders.

Conclusions

Psychopharmaceuticals exert a substantial impact on sleep architecture, with effects contingent on drug class and duration of use. Understanding these alterations is crucial for optimizing the treatment of patients with psychiatric disorders, striking a balance between therapeutic benefits and potential sleep-related adverse effects. Furthermore, these discoveries underscore the importance of closely monitoring the sleep of patients undergoing psychopharmacological treatment and tailoring therapeutic approaches in accordance with individual needs.

Disclosure of Interest

None Declared

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.